
Law firm probes Myriad Genetics for potential securities fraud after revenue drop and guidance cut.
Kirby McInerney LLP is investigating Myriad Genetics for possible securities fraud following the company's report of an 11% revenue decline in Q2 2026 and a lowered full-year revenue forecast. The company also disclosed an $11 million revenue reducti...

